EGFR and lung cancer: A recent mouse lung cancer model study found that Malt1 controls Stat3 activation in vivo downstream of EGFR through NF-κB-dependent autocrine/paracrine IL-6 production61, raising the possibility that the Malt1 pathway may intersect the Stat3 pathway in Th17 cells.